Pediatric Protections Extended To Infant Formula, Dietary Ingredient Studies
This article was originally published in The Tan Sheet
Executive Summary
HHS protections covering children involved in clinical trials are extended to studies of new dietary supplement ingredients and infant formulas, as well as research supporting petitions for nutrient content or health claims, under an FDA interim rule published in the Federal Register April 24.